BOLDEUR
Audentes Therapeutics Inc
Early-stage biotechnology company developing gene therapies for rare life-threatening genetic diseases
CUSIP: 05070R104HealthcareUS1 holder
Recent Activity
2016Q4
1 sell
-45.8K shares
Leon CoopermanEXIT
-45.8K shares
Loading more activity...